Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease

Lancet Diabetes Endocrinol. 2023 Dec;11(12):926-941. doi: 10.1016/S2213-8587(23)00224-3. Epub 2023 Oct 18.

Abstract

Despite widespread sex differences in prevalence and presentation of numerous illnesses affecting the human brain, there has been little focus on the effect of endocrine ageing. Most preclinical studies have focused on males only, and clinical studies often analyse data by covarying for sex, ignoring relevant differences between the sexes. This sex- (and gender)-neutral approach is biased and contributes to the absence of targeted treatments and services for all sexes (and genders). Female health has been historically understudied, with grave consequences for their wellbeing and health equity. In this Review, we spotlight female brain health across the lifespan by informing on the role of sex steroids, particularly oestradiol, on the female brain and on risk for diseases more prevalent in females, such as depression and Alzheimer's disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / epidemiology
  • Brain
  • Depression / epidemiology
  • Female
  • Humans
  • Longevity
  • Male
  • Sex Characteristics
  • Steroids

Substances

  • Steroids